Nov 18, 2016 02:30 am UTC| Business
NEW YORK, Nov. 17, 2016 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Treehouse Foods, Inc. (“Treehouse” or the “Company”) (NYSE:THS) of the January 17, 2017 deadline to seek the...
First Hawaiian Names Joel Rappoport General Counsel and Corporate Secretary
Nov 18, 2016 01:30 am UTC| Business
HONOLULU, Nov. 17, 2016 -- Joel Rappoport, a partner with the law firm Kilpatrick Townsend Stockton LLP, Washington DC, will be joining First Hawaiian Bank’s Senior Management Committee and has been named executive...
Triphase Accelerator Announces Acquisition of its First Compound, Marizomib, by Celgene Corporation
Nov 18, 2016 01:21 am UTC| Business
Marizomib is a novel brain-penetrant proteasome inhibitor in development for patients with glioblastoma and relapsed and/or refractory multiple myeloma. TORONTO and SAN DIEGO, Nov. 17, 2016 -- Triphase Accelerator...
Nov 18, 2016 01:00 am UTC| Business
NEW YORK, Nov. 17, 2016 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Alexion Pharmaceuticals, Inc. (“Alexion” or the “Company”) (NASDAQ:ALXN) of the January 17, 2017. deadline to...
Coherus BioSciences Announces New Employment Inducement Grants
Nov 18, 2016 00:49 am UTC| Business
REDWOOD CITY, Calif., Nov. 17, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that effective November 17, 2016, the compensation committee of the company’s board of directors granted 6 new employees...
The emotions at play when customers con businesses
Nov 18, 2016 00:31 am UTC| Research & Analysis Business
Customers who are fearful are more likely to be ethical in a tricky situation as the stakes increase, while angry customers will behave unethically no matter what the stakes, our research shows. In our study, we...
BeiGene Announces Pricing of $200 Million Public Offering
Nov 18, 2016 00:27 am UTC| Business
WALTHAM, Mass., Nov. 17, 2016 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced...